Clinical Trial Update: A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating JNJ-90301900 in combination with chemoradiation therapy for locally advanced head and neck squamous cell carcinoma is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• JNJ-90301900

Snippet

Sponsor: Johnson & Johnson Enterprise Innovation Inc. | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 1 | Status: RECRUITING